NCT05942482 is a clinical trial in Head and Neck Paraganglioma, sponsored by Pamukkale University.

Who is sponsoring NCT05942482?

NCT05942482 is sponsored by Pamukkale University.

What condition does NCT05942482 study?

NCT05942482 studies Head and Neck Paraganglioma.

Is NCT05942482 still recruiting?

NCT05942482 is currently completed. Last updated 15 September 2023.

Last reviewed 2023-09-15 · How we verify

NCT05942482

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Head and Neck Paragangliomas: A 16-year Experience of a University Hospital in Turkey

Completed Last updated 15 September 2023

What this trial tests

trial in Head and Neck Paraganglioma in 39 participants. Completed in 5 July 2023.

Timeline

30 June 2023

Primary endpoint
5 July 2023

5 July 2023

Quick facts

Lead sponsor	Pamukkale University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	39
Start date	30 June 2023
Primary completion	5 July 2023
Estimated completion	5 July 2023
Sites	1 location across Turkey (Türkiye)

Conditions studied

Head and Neck Paraganglioma — all drugs for Head and Neck Paraganglioma →

Sponsor

Pamukkale University

Who can join

Eligibility, any sex, with Head and Neck Paraganglioma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to examine the head and neck paraganglioma cases treated in Pamukkale University hospital between 2007-2023 and improve our understanding of these cases and contribute to the knowledge surrounding head and neck paragangliomas.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Head and Neck Paragangliomas: 16-year Single-center Experience and Mini Review on Diagnosis, Treatment, and Follow-up.
Aydemir G, Ardic FN, Kara CO, Bir F. · · 2024 · PMID 39350541 · DOI 10.4274/mmj.galenos.2024.91668

Verify or expand the search:

Other Pamukkale University trials

Trials by the same sponsor.

NCT06667856 — Foot Core Exercise Training With Telerehabilitation · NA · suspended
NCT07532499 — EMG-Triggered Electrical Stimulation After Median/Ulnar Nerve Repairs · NA · not yet recruiting
NCT07473232 — Comparison of Platelet-rich Plasma and Activated Cytokine-rich Serum Injection Treatments in Patients With Knee Osteoart · NA · not yet recruiting
NCT07520084 — Predictors of Climate Change Health Literacy in Older Individuals · recruiting
NCT07388316 — Functional Improvement and Fine Dexterity in Thumb Tendon Injuries · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05942482 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pamukkale University
Last refreshed: 15 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05942482.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing